Cannabis brands often approve a cartridge sample and then place a production order based solely on the product description. That shortcut leaves the filling partner, packaging team, and vape supplier to resolve important details after the purchase order has been submitted. A “controlled specification packet” must include formulation, critical dimensions, closure process, materials, lot records, and change rules, all decided on before the production clock starts.
Consider a production meeting in which purchasing has an approved sample, but the filler cannot locate the delivered cartridge consistently in its tray. The purchase order offers little insight into why the elements don’t work since the description only says “one-gram ceramic 510.”
Nobody necessarily shipped the wrong item. The company looking for a vape supplier based its purchasing decision on a basic product description rather than specifying defined configurations.
That distinction matters because a vape cartridge is handled by more than its buyer. It has to accept a particular formulation, go through a filling and closing process, fit a fixture, survive packing and distribution, and remain traceable to the approved version. If those interfaces live in separate email threads, the first production lot becomes the point at which the team discovers what it forgot to agree on.
A controlled specification packet gives the team a common target for validation, testing, and jurisdiction-specific legal review.
The RFQ should begin with the oil
Catalog labels encourage buyers to start with capacity, coil type, and thread. Operations usually need a different first question: what will go into the cartridge?
“Cannabis oil” does not describe one set of flow characteristics. A formulation may behave differently as temperature changes or after added terpenes and other permitted ingredients alter it. Those differences can affect how readily the reservoir fills, whether oil reaches the intake openings as intended, and how much time the operator has before closing the unit.
The brand does not need to disclose a proprietary recipe in an initial request for quotation. It can provide a bounded process description: the viscosity range measured at a stated temperature, planned fill temperature, target fill amount, and any known material restrictions. For qualification, the parties can agree on a representative fluid or a controlled sample of the intended formulation.
This is where shortcuts are tempting. Sending a representative fluid sample takes time, and some suppliers will offer a quick recommendation based on a broad oil description. That recommendation may be a sensible starting point. It is not a substitute for confirming the final model with the actual formulation and operating conditions.
ASTM International publishes separate classification and guidance documents for cannabis/hemp extract vaporizers.¹ For a buyer, the practical starting point is simply to use consistent terms for the device being evaluated. Suitability for a particular extract still has to be established for the selected model and operating conditions.
“One gram” leaves a volume question unanswered
Brands sell by net weight. Reservoirs are physical volumes. Treating the two as interchangeable creates avoidable arguments at the filling line.
The specification should distinguish the cartridge’s nominal reservoir volume from the target net fill. It should then state the allowed fill tolerance and the agreed maximum fill level or headspace for the selected formulation. These are related values, but they are not the same value.
There is no responsible universal conversion to paste into every specification. Density is part of the formulation, and usable volume depends on the particular cartridge and closing process. The correct numbers come from measurement under defined conditions.
The filling instructions should capture the details that change the result: product temperature at dispense, needle position, dispense approach, and maximum interval between filling and closure. If the center airway collects oil during filling, the first question should not be whether the cartridge is “good” or “bad.” The team should first confirm that it used the same fill conditions under which the hardware was qualified.
Approve a drawing, not a photograph
A commercial image helps identify a style. It cannot locate a part in a nest or size a carton insert.
The released drawing should show the dimensions used downstream, including overall height after closure, maximum diameter, base geometry, connection details, and the surfaces used to locate the part in a tray or fixture. The team should mark which dimensions are critical to fit or function. Cosmetic dimensions and fixture interfaces should not receive the same attention merely because both appear on the page.
Buyers sometimes ask for tighter tolerances everywhere because it feels safer. That can add cost without improving the process. The better discussion is specific: Which dimension controls centering under the fill needle? Which surface determines press depth? Which assembled height controls the package? Those are the dimensions that purchasing, the supplier, the filler, and packaging must understand the same way.
The drawing also needs a part number and revision. The approved sample, quotation, purchase order, inspection record, and packaging file should point to that revision. A model name alone cannot do this job. Suppliers may improve tooling or substitute a subcomponent while continuing to sell under the same name.
A press-fit mouthpiece is a process step
The words “press fit” do not tell an operator how to close a cartridge.
A workable closure instruction identifies where the fixture contacts the part, how the cartridge is supported, the required final position, and how the operator confirms that closure is acceptable. If force or travel limits are part of the qualified process, those limits belong in the instruction along with the equipment and fixture used to establish them.
Mouthpiece geometry, seal design, materials, and equipment vary, so a closure-force value from another model may not apply. The supplier should provide model-specific starting information, and the processor should establish the operating window during qualification.
This step is also where three schedules collide. The supplier wants to release hardware. The filler wants final nests and closing tooling. Packaging wants the post-closure dimensions. If the brand approves artwork and inserts from an early rendering, a small change at the closure interface can create packaging rework even when the cartridge functions as intended.
“Ceramic” identifies one component, not the assembly
Cartridges described as ceramic still contain an assembly of materials. Depending on the model, that may include metal alloys, glass, polymers, seals, adhesives, surface finishes, and a ceramic heating or wicking component. The relevant disclosure maps each material to a component and identifies its relationship to the formulation and aerosol pathway.
The material record serves a practical purpose. In a peer-reviewed study of unused cannabis vape pens, researchers observed metal-containing particles in the liquid and reported variation between devices filled with liquid from the same product lot. The identified particles included metals used in common device alloys.² Section 5.3.5 of Health Canada’s industry guide states that studies suggest coil type and composition, device power setting, device type, and user behavior could contribute to the release of elements. The same section recommends that manufacturers control harmful elements in devices and parts so their transmission to aerosol under normal use is minimized.³
Those findings do not predict the performance of a particular cartridge or create a universal test plan. They are a reason to ask what a certificate actually tested.
When reviewing a report, ask what was actually tested. Was it raw material, empty hardware, liquid after contact, or generated aerosol? Which model and revision? Which formulation, storage interval, operating conditions, sample count, method, and acceptance criteria? Does the report identify a production lot?
That checklist is a procurement recommendation, not a requirement taken from the cited study. Its purpose is to prevent a valid report from being applied to a product it did not evaluate.
Decide which evidence belongs to the model and which belongs to the lot
Two folders often get mixed together.
The first supports model qualification. It may contain the released drawing, component-level material declarations, relevant test reports, process information, and records of validation of the brand’s formulation and filling method.
The second travels with production lots. It should identify the part number and revision, lot or batch code, manufacturing date where applicable, quantity, and agreed inspection or conformance records. The exact contents depend on the risk assessment and the parties’ quality agreement.
The distinction keeps document requests honest. Asking a supplier for “all certifications” produces a large attachment folder and very little certainty. Asking for the test report applicable to revision C and the conformance record for lot 2407 makes the traceability question answerable.
Receiving inspection should be equally focused. Verify the few characteristics that would stop production or break traceability: correct revision, lot identity, packaging condition, and the critical dimensions or assembly features selected during qualification. The sampling method and acceptance rule should be agreed before delivery so receiving staff are not forced to improvise when a result falls outside the target.
Expect resistance to change control
Change notification is easy to endorse and harder to negotiate. Suppliers may treat sub-supplier identities, detailed bills of material, or proprietary processes as confidential. Buyers may respond by asking for everything, which usually produces boilerplate rather than usable control.
A narrower agreement works better. Define the changes that affect the approved interface or risk assessment: formulation and contact materials, heating components, seals, critical dimensions, assembly method, tooling, manufacturing site, and critical sub-suppliers. Then agree on the notice period and the response. Some changes may require only a document review. Others may require samples or requalification.
This negotiation has to happen before the order. Once inventory is built and a launch date is fixed, both sides have an incentive to treat a change as minor.
If a supplier will not disclose proprietary composition, the brand can still request stable material identifiers, a declaration of no change, or an agreed-upon notification category. The objective is not to acquire the supplier’s trade secrets. It is to know when the qualified configuration is no longer the configuration being shipped.
The two-page packet is better than the twelve-page packet nobody uses
Start with the smallest controlled document that can travel across purchasing, quality, filling, and packaging. For many teams, the core can fit on two pages plus attachments.
Page one identifies the product: part number, revision, intended formulation conditions, nominal reservoir volume, target fill, and approved configuration. Page two controls the handoffs: critical drawing references, fill and closure instructions, fixture and packaging interfaces, required lot records, receiving checks, and change-notification rules.
Figure 1 summarizes how those handoffs connect from formulation through packaging while lot evidence and change notification preserve the approved revision.
The drawing, material declaration, and test reports sit behind those pages as controlled attachments. One owner maintains the packet. Each affected function approves the fields it actually uses.
This will add work to the RFQ. It should. The choice is whether the team resolves those questions while it can still change a drawing and schedule a trial, or after thousands of cartridges are waiting beside a filling line.
Copyright
© Cannabis Industry Journal